Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025


Delayed Quote. Delayed Nyse - 10/24 04:00:32 pm
184.21 USD   +0.46%
2d ago ALLERGAN : Announces Quarterly Conference Call
5d ago Stronger oil stocks and surge in Shire lift FTSE
5d ago ALLERGAN : Valeant may up Allergan offer
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 07:11pm US/Eastern
   By Anjali Athavaley 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912;

Latest news on ALLERGAN, INC.
2d ago ALLERGAN : Announces Quarterly Conference Call
3d ago ALLERGAN : Patent Issued for Variable Cohesive Gel Form-Stable Breast Implant
3d ago ALLERGAN : Patent Issued for Compositions Containing Alpha-2-Adrenergic Agonist ..
3d ago ALLERGAN : Patent Issued for Biological Tissue Growth through Induced Tensile St..
3d ago ALLERGAN : Patent Issued for Interior Needle Stick Guard Stems for Tubes
4d ago ALLERGAN : Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in th..
5d ago JOHN PAULSON : John Paulson's Solution To Shire Problem Probably Not Sitting Wel..
5d ago Stronger oil stocks and surge in Shire lift FTSE
5d ago ALLERGAN : Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredi..
5d ago ALLERGAN : Valeant may up Allergan offer
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes